KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now available to ...
A breakthrough in the translation of genetic mechanisms and traits that can influence a person’s behavioral predispositions, Genomind Mental Health Map provides the starting point to empower consumers ...
CHALFONT, PA--(Marketwired - February 06, 2014) - For some patients, the key to successful behavioral health treatment may be in their genes. That's the concept behind a new program at Princeton House ...
KING OF PRUSSIA, PA--(Marketwired - September 22, 2015) - Genomind, a personalized medicine company bringing innovation to mental health care through genetic testing, announced the closing of a $6 ...
GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...
A King of Prussia, Pa., personalized medicine company that has developed a genetic test to help clinicians make more informed treatment decisions for patients with depression has raised another $3.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback